111 related articles for article (PubMed ID: 36336105)
21. Fe(iii)-Catalyzed synthesis of steroidal imidazoheterocycles as potent antiproliferative agents.
Samanta S; Ghosh AK; Ghosh S; Ilina AA; Volkova YA; Zavarzin IV; Scherbakov AM; Salnikova DI; Dzichenka YU; Sachenko AB; Shirinian VZ; Hajra A
Org Biomol Chem; 2020 Aug; 18(29):5571-5576. PubMed ID: 32662797
[TBL] [Abstract][Full Text] [Related]
22. CUDC-101, a Novel Inhibitor of Full-Length Androgen Receptor (flAR) and Androgen Receptor Variant 7 (AR-V7) Activity: Mechanism of Action and In Vivo Efficacy.
Sun H; Mediwala SN; Szafran AT; Mancini MA; Marcelli M
Horm Cancer; 2016 Jun; 7(3):196-210. PubMed ID: 26957440
[TBL] [Abstract][Full Text] [Related]
23. Androgen receptor antagonists and anti-prostate cancer activities of some synthesized steroidal candidates.
Bahashwan SA; Al-Omar MA; Ezzeldin E; Abdalla MM; Fayed AA; Amr AG
Chem Pharm Bull (Tokyo); 2011; 59(11):1363-8. PubMed ID: 22041072
[TBL] [Abstract][Full Text] [Related]
24. Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant prostate cancer.
Khurana N; Kim H; Chandra PK; Talwar S; Sharma P; Abdel-Mageed AB; Sikka SC; Mondal D
Oncol Rep; 2017 Nov; 38(5):2774-2786. PubMed ID: 28901514
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, 17α-hydroxylase-C
Banday AH; Shameem SA; Banday JA; Ganaie BA
Anticancer Agents Med Chem; 2018; 18(13):1919-1926. PubMed ID: 29697032
[TBL] [Abstract][Full Text] [Related]
26. Tetrahydropyrazolo[1,5-a]pyridine-fused steroids and their in vitro biological evaluation in prostate cancer.
Jorda R; Lopes SMM; Řezníčková E; Ajani H; Pereira AV; Gomes CSB; M V D Pinho E Melo T
Eur J Med Chem; 2019 Sep; 178():168-176. PubMed ID: 31181481
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, In Vitro Biological Evaluation of Antiproliferative and Neuroprotective Effects and In Silico Studies of Novel 16
Brito V; Marques M; Esteves M; Serra-Almeida C; Alves G; Almeida P; Bernardino L; Silvestre S
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979790
[TBL] [Abstract][Full Text] [Related]
28. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study.
Chen J; Wang WQ; Lin SX
J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, Aromatase Inhibitory, Antiproliferative and Molecular Modeling Studies of Functionally Diverse D-Ring Pregnenolone Pyrazoles.
Banday AH; Saeed BA; Al-Masoudi NA
Anticancer Agents Med Chem; 2021; 21(13):1671-1679. PubMed ID: 33238853
[TBL] [Abstract][Full Text] [Related]
30. Discovery and biological evaluation of darolutamide derivatives as inhibitors and down-regulators of wild-type AR and the mutants.
Yu J; Zhou P; Hu M; Yang L; Yan G; Xu R; Deng Y; Li X; Chen Y
Eur J Med Chem; 2019 Nov; 182():111608. PubMed ID: 31437779
[TBL] [Abstract][Full Text] [Related]
31. Effects of new C6-substituted steroidal aromatase inhibitors in hormone-sensitive breast cancer cells: Cell death mechanisms and modulation of estrogen and androgen receptors.
Augusto TV; Amaral C; Varela CL; Bernardo F; da Silva ET; Roleira FFM; Costa S; Teixeira N; Correia-da-Silva G
J Steroid Biochem Mol Biol; 2019 Dec; 195():105486. PubMed ID: 31557516
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic Potential of Leelamine, a Novel Inhibitor of Androgen Receptor and Castration-Resistant Prostate Cancer.
Singh KB; Ji X; Singh SV
Mol Cancer Ther; 2018 Oct; 17(10):2079-2090. PubMed ID: 30030299
[TBL] [Abstract][Full Text] [Related]
33. In vitro cytotoxic effect of stigmasterol derivatives against breast cancer cells.
Dube NP; Tembu VJ; Nyemba GR; Davison C; Rakodi GH; Kemboi D; de la Mare JA; Siwe-Noundou X; Manicum AE
BMC Complement Med Ther; 2023 Sep; 23(1):316. PubMed ID: 37697361
[TBL] [Abstract][Full Text] [Related]
34. Efficient access to novel androsteno-17-(1',3',4')-oxadiazoles and 17β-(1',3',4')-thiadiazoles via N-substituted hydrazone and N,N'-disubstituted hydrazine intermediates, and their pharmacological evaluation in vitro.
Kovács D; Wölfling J; Szabó N; Szécsi M; Minorics R; Zupkó I; Frank É
Eur J Med Chem; 2015 Jun; 98():13-29. PubMed ID: 25993309
[TBL] [Abstract][Full Text] [Related]
35. Two new polyhydroxylated steroids from Egyptian soft coral
Abdelkarem FM; Desoky EK; Nafady AM; Allam AE; Mahdy A; Ashour A; Mohamed GA; Miyamoto T; Shimizu K
Nat Prod Res; 2021 Jan; 35(2):236-243. PubMed ID: 31170807
[TBL] [Abstract][Full Text] [Related]
36. High-Content Screening Identifies Src Family Kinases as Potential Regulators of AR-V7 Expression and Androgen-Independent Cell Growth.
Szafran AT; Stephan C; Bolt M; Mancini MG; Marcelli M; Mancini MA
Prostate; 2017 Jan; 77(1):82-93. PubMed ID: 27699828
[TBL] [Abstract][Full Text] [Related]
37. 1-Benzyloxy-5-phenyltetrazole derivatives highly active against androgen receptor-dependent prostate cancer cells.
Zhao S; Ali AS; Kong X; Zhang Y; Liu X; Skidmore MA; Forsyth CM; Savage GP; Wu D; Xu Y; Francis CL
Eur J Med Chem; 2023 Jan; 246():114982. PubMed ID: 36495632
[TBL] [Abstract][Full Text] [Related]
38. Dihydrotestosterone-based A-ring-fused pyridines: Microwave-assisted synthesis and biological evaluation in prostate cancer cells compared to structurally related quinolines.
Kiss MA; Peřina M; Bereczki L; Baji Á; Bělíček J; Jorda R; Frank É
J Steroid Biochem Mol Biol; 2023 Jul; 231():106315. PubMed ID: 37086925
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and Characterization of New Series of 1,3-5-Triazine Hydrazone Derivatives with Promising Antiproliferative Activity.
H Al Rasheed HHA; M Malebari AM; A Dahlous KA; El-Faham A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32545272
[TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of novel steroidal imidazoles as dual inhibitors of AR/CYP17 for the treatment of prostate cancer.
Hou Q; He C; Lao K; Luo G; You Q; Xiang H
Steroids; 2019 Oct; 150():108384. PubMed ID: 30885648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]